SMAD2 and cancer: As a member of an E3 ligase NEDD4 family, NEDD4L not only targets membrane proteins including ion channels and transporters, but also triggers the degradation of certain proteins involved in cancer signaling pathways such as Dvl2, SMAD2, and SMAD7 [33, 34].